Abstract
Methylated analogues of imidazoline related compounds (IRC) were prepared; their abilities to bind I(1) imidazoline receptors (I(1)Rs), I(2) imidazoline binding sites (I(2)BS) and α(2)-adrenoceptor subtypes (α(2)ARs) were assessed. Methylation of the heterocyclic moiety of IRC resulted in a significant loss of α(2)AR affinity. Amongst the selective ligands obtained, LNP 630 (4) constitutes the first highly selective I(1)R agent showing hypotensive activity after intravenous administration.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Binding Sites / drug effects
-
CHO Cells
-
Cricetinae
-
Humans
-
Imidazoline Receptors / chemistry*
-
Imidazoline Receptors / metabolism
-
Imidazolines / administration & dosage
-
Imidazolines / chemistry*
-
Imidazolines / pharmacology*
-
Injections, Intravenous
-
Ligands
-
Male
-
Methylation
-
Molecular Structure
-
PC12 Cells
-
Rats
-
Rats, Inbred SHR
-
Receptors, Adrenergic, alpha-2 / chemistry*
-
Receptors, Adrenergic, alpha-2 / metabolism
-
Structure-Activity Relationship
Substances
-
Imidazoline Receptors
-
Imidazolines
-
Ligands
-
Receptors, Adrenergic, alpha-2
-
imidazoline I1 receptors
-
imidazoline receptor 2